Maximilian Plank

1.7k total citations
27 papers, 1.3k citations indexed

About

Maximilian Plank is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Maximilian Plank has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Physiology. Recurrent topics in Maximilian Plank's work include Asthma and respiratory diseases (9 papers), MicroRNA in disease regulation (7 papers) and Respiratory and Cough-Related Research (4 papers). Maximilian Plank is often cited by papers focused on Asthma and respiratory diseases (9 papers), MicroRNA in disease regulation (7 papers) and Respiratory and Cough-Related Research (4 papers). Maximilian Plank collaborates with scholars based in Australia, United States and United Kingdom. Maximilian Plank's co-authors include Paul S. Foster, Joërg Mattes, Adam Collison, Simon Phipps, Steven Maltby, Hock L. Tay, Philip M. Hansbro, Gerard E. Kaiko, Ming Yang and Kim Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Maximilian Plank

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian Plank Australia 15 535 528 498 231 185 27 1.3k
Rocío T. Martínez-Núñez United Kingdom 14 616 1.2× 489 0.9× 408 0.8× 144 0.6× 73 0.4× 30 1.1k
Olivia Prazeres da Costa Germany 16 455 0.9× 186 0.4× 758 1.5× 154 0.7× 190 1.0× 25 1.5k
Malay Haldar United States 16 788 1.5× 124 0.2× 963 1.9× 174 0.8× 136 0.7× 20 1.8k
Kaleb M. Pauley United States 15 1.3k 2.5× 1.2k 2.3× 542 1.1× 196 0.8× 78 0.4× 18 2.2k
Tomasz Szul United States 19 810 1.5× 175 0.3× 187 0.4× 115 0.5× 377 2.0× 28 1.4k
Mark M. Perry United Kingdom 18 1.4k 2.6× 1.3k 2.4× 435 0.9× 285 1.2× 282 1.5× 26 2.2k
Michael Novotny United States 16 300 0.6× 231 0.4× 686 1.4× 106 0.5× 77 0.4× 22 1.1k
Cristiane Damas Gil Brazil 20 765 1.4× 115 0.2× 592 1.2× 80 0.3× 97 0.5× 75 1.3k
Liyang Dong China 19 674 1.3× 444 0.8× 371 0.7× 70 0.3× 137 0.7× 54 1.3k
Kun Du China 17 936 1.7× 617 1.2× 112 0.2× 191 0.8× 61 0.3× 53 1.4k

Countries citing papers authored by Maximilian Plank

Since Specialization
Citations

This map shows the geographic impact of Maximilian Plank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Plank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Plank more than expected).

Fields of papers citing papers by Maximilian Plank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian Plank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Plank. The network helps show where Maximilian Plank may publish in the future.

Co-authorship network of co-authors of Maximilian Plank

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Plank. A scholar is included among the top collaborators of Maximilian Plank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Plank. Maximilian Plank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, James F., Ashley Woodcock, Antonio Anzueto, et al.. (2025). Decarbonising Respiratory Care: The Impact of a Low‐Carbon Salbutamol Pressurised Metered‐Dose Inhalers. Allergy.
2.
Daley‐Yates, Peter T., Bhumika Aggarwal, & Maximilian Plank. (2024). Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids. Advances in Therapy. 41(5). 1995–2009. 6 indexed citations
3.
4.
5.
Maneechotesuwan, Kittipong, Bhumika Aggarwal, Gabriel García, et al.. (2024). Exploring Clinical Remission in Moderate Asthma – Perspectives from Asia, the Middle East, and South America. Pulmonary Therapy. 10(3). 279–295. 3 indexed citations
6.
Daley‐Yates, Peter T., Dave Singh, J Igea, et al.. (2023). Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management. Advances in Therapy. 40(9). 4042–4059. 5 indexed citations
7.
8.
Plank, Maximilian, Kelly L. Asquith, Steven Maltby, et al.. (2021). T-helper 22 cells develop as a distinct lineage from Th17 cells during bacterial infection and phenotypic stability is regulated by T-bet. Mucosal Immunology. 14(5). 1077–1087. 15 indexed citations
9.
Jones, Kim, Steven Maltby, Maximilian Plank, et al.. (2017). Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke. Brain Behavior and Immunity. 67. 299–307. 104 indexed citations
10.
Marks, Ellen, Crystal Naudin, Garry P. Nolan, et al.. (2017). Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation. Mucosal Immunology. 10(5). 1224–1236. 33 indexed citations
11.
Maltby, Steven, Maximilian Plank, Hock L. Tay, Adam Collison, & Paul S. Foster. (2016). Targeting MicroRNA Function in Respiratory Diseases: Mini-Review. Frontiers in Physiology. 7. 21–21. 60 indexed citations
12.
Plank, Maximilian, Steven Maltby, Hock L. Tay, et al.. (2015). MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity. PLoS ONE. 10(12). e0144810–e0144810. 61 indexed citations
13.
Tay, Hock L., Gerard E. Kaiko, Maximilian Plank, et al.. (2015). Antagonism of miR-328 Increases the Antimicrobial Function of Macrophages and Neutrophils and Rapid Clearance of Non-typeable Haemophilus Influenzae (NTHi) from Infected Lung. PLoS Pathogens. 11(4). e1004549–e1004549. 56 indexed citations
14.
Tay, Hock L., Maximilian Plank, Adam Collison, et al.. (2014). MicroRNA: Potential biomarkers and therapeutic targets for allergic asthma?. Annals of Medicine. 46(8). 633–639. 22 indexed citations
15.
Maltby, Steven, Maximilian Plank, Catherine Ptaschinski, Joërg Mattes, & Paul S. Foster. (2014). MicroRNA Function in Mast Cell Biology: Protocols to Characterize and Modulate MicroRNA Expression. Methods in molecular biology. 1220. 287–304. 11 indexed citations
16.
Li, Jing Jing, Hock L. Tay, Maximilian Plank, et al.. (2013). Activation of Olfactory Receptors on Mouse Pulmonary Macrophages Promotes Monocyte Chemotactic Protein-1 Production. PLoS ONE. 8(11). e80148–e80148. 36 indexed citations
17.
Alves, Caio César de Souza, Adam Collison, Luke Hatchwell, et al.. (2013). Inhibiting AKT Phosphorylation Employing Non-Cytotoxic Anthraquinones Ameliorates TH2 Mediated Allergic Airways Disease and Rhinovirus Exacerbation. PLoS ONE. 8(11). e79565–e79565. 18 indexed citations
18.
Collison, Adam, Joërg Mattes, Maximilian Plank, & Paul S. Foster. (2011). Inhibition of house dust mite–induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. Journal of Allergy and Clinical Immunology. 128(1). 160–167.e4. 180 indexed citations
19.
Mattes, Joërg, Adam Collison, Maximilian Plank, Simon Phipps, & Paul S. Foster. (2009). Antagonism of microRNA-126 suppresses the effector function of T H 2 cells and the development of allergic airways disease. Proceedings of the National Academy of Sciences. 106(44). 18704–18709. 359 indexed citations
20.
Mattes, Joërg, Adam Collison, Maximilian Plank, Simon Phipps, & PS Foster. (2009). MicroRNAs Regulate Allergic Airway Inflammation.. A5456–A5456.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rocío T. Martínez-Núñez Breakdown of academic impact, for papers by Olivia Prazeres da Costa Breakdown of academic impact, for papers by Malay Haldar Breakdown of academic impact, for papers by Kaleb M. Pauley Breakdown of academic impact, for papers by Tomasz Szul Breakdown of academic impact, for papers by Mark M. Perry Breakdown of academic impact, for papers by Michael Novotny Breakdown of academic impact, for papers by Cristiane Damas Gil Breakdown of academic impact, for papers by Liyang Dong Breakdown of academic impact, for papers by Kun Du
Rankless by CCL
2026